GlassScriptPhysician profile
Michael Curtis Shockley
NPI 1891792651
$1,104.44
in general payments reported to CMS, 2019-2025
16 companies · $44.60 in 2025
The $44.60 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $326 · 2021: $244 · 2022: $40.43 · 2024: $83.36 · 2025: $44.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.18 | 2019-2021 | |
| Minerva Surgical, INC | $259.76 | 2019-2022 | |
| Hologic Sales and Service, LLC | $105.76 | 2020-2024 | Coolseal Generator |
| Pfizer INC. | $103.94 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.10 | 2019-2020 | |
| Novo Nordisk INC | $44.60 | 2025 | Ozempic, Rybelsus |
| Allergan, INC. | $38.59 | 2020 | |
| Therapeuticsmd, INC. | $37.82 | 2019-2020 | |
| Astellas Pharma US INC | $36.42 | 2019 | |
| Merck Sharp & Dohme LLC | $33.02 | 2019 | |
| Stryker Corporation | $24.78 | 2022 | |
| Amgen INC. | $20.65 | 2019 | |
| Avanos Medical | $20.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.94 | 2020 | |
| Myovant Sciences INC. | $16.35 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shockley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.